This month, an approval was granted by Romanian National Agency for Medicines and Medical Devices to conduct the study in patients with inoperable liver cancers non-responding to standard therapy. Promising research is being carried out by GCT team in Romania and sponsored by a EU based company. The patient enrollment is expected to start shortly following the Investigator Meeting in Bucharest.
GCT has an extensive Oncology expertise in EU, Russia, Ukraine and USA, and this project is another opportunity for the company to enhance it.
Pictured: Monument of Rebirth in front of the MOH building in Bucharest, Romania, image courtesy by Dennis Jarvis under CC BY-SA 2.0